Skip to main content
Contact
Site Search
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Home
About
Who We Are
Leadership
Our Legacy
Science
Overview
Publications
Pipeline
Overview
Clinical Trials
Patients
Therapeutic Focus
Patient Resources
Access Policy
News/Events
Overview
Press Releases
Events & Presentations
Email and News Alerts
Careers
Overview
Our Values
Inside Momenta
Benefits
Search Openings
Press Releases
Home
>
News/Events
>
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
12/24/2019
Momenta Pharmaceuticals to Webcast Presentation at the 38th Annual J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)
12/13/2019
Momenta Pharmaceuticals Appoints Dr. Jane F. Barlow to Board of Directors
Download
PDF format download (opens in new window)
12/12/2019
Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Download
PDF format download (opens in new window)
12/10/2019
Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
11/07/2019
Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition
Download
PDF format download (opens in new window)
11/06/2019
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Download
PDF format download (opens in new window)
10/31/2019
Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results
Download
PDF format download (opens in new window)
10/17/2019
Momenta Pharmaceuticals Announces Date of Third Quarter 2019 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
09/19/2019
Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of Directors
Download
PDF format download (opens in new window)
08/02/2019
Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results
Download
PDF format download (opens in new window)
08/01/2019
Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic Anemia and is Granted FDA Fast Track Designation
Download
PDF format download (opens in new window)
07/30/2019
Momenta Pharmaceuticals Announces Fast Track Designation for M281 (nipocalimab) in Hemolytic Disease of the Fetus and Newborn (HDFN)
Download
PDF format download (opens in new window)
07/19/2019
Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
06/19/2019
Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation
Download
PDF format download (opens in new window)
06/04/2019
Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 40th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
05/09/2019
Momenta Pharmaceuticals to Webcast Presentation at the 2019 Bank of America Merrill Lynch Healthcare Conference
Download
PDF format download (opens in new window)
05/02/2019
Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results
Download
PDF format download (opens in new window)
04/18/2019
Momenta Pharmaceuticals Announces Date of First Quarter 2019 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
03/28/2019
Momenta Pharmaceuticals Announces Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019
Download
PDF format download (opens in new window)
03/21/2019
Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit Maternal-Fetal IgG Transfer in the Human Term Placenta
Download
PDF format download (opens in new window)
02/22/2019
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
Download
PDF format download (opens in new window)
02/08/2019
Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2018 Financial Results Conference Call and Webcast
Download
PDF format download (opens in new window)
02/07/2019
Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting
Download
PDF format download (opens in new window)
01/29/2019
Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G
Download
PDF format download (opens in new window)
01/02/2019
Momenta Pharmaceuticals to Webcast Presentation at the 37th Annual J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)